Cingulate News

Maxim Group Maintains Cingulate(CING.US) With Hold Rating

Moomoo NewsAug 14 13:32 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cingulate Inc (CING), Indaptus Therapeutics (INDP) and Immunocore Holdings (IMCR)

TipRanksMay 24 12:15 ET

Analysts Conflicted on These Healthcare Names: Cingulate Inc (CING) and Genenta Science SpA Sponsored ADR (GNTA)

TipRanksMay 10 11:10 ET

Cingulate Inc (CING) Receives a Hold From Maxim Group

TipRanksApr 4 11:05 ET

Cingulate Analyst Ratings

BenzingaJan 5 07:40 ET

Cingulate Analyst Ratings

BenzingaDec 22, 2023 04:40 ET

Cingulate Analyst Ratings

BenzingaDec 19, 2023 09:47 ET

Cingulate Analyst Ratings

BenzingaDec 18, 2023 11:36 ET

Cingulate Inc's Strong Financial Position and Promising ADHD Drug Development Prospects Garner Buy Rating From Maxim Group

TipRanksNov 16, 2023 15:45 ET

Analysts Offer Insights on Healthcare Companies: Cano Health (CANO), Personalis (PSNL) and Cingulate Inc (CING)

TipRanksOct 25, 2023 06:20 ET

HC Wainwright & Co. Maintains Buy on Cingulate, Lowers Price Target to $3.5

BenzingaSep 26, 2023 06:27 ET

Cingulate Analyst Ratings

BenzingaSep 26, 2023 06:25 ET

Analysts Are Bullish on Top Healthcare Stocks: Cingulate Inc (CING), Achieve Life Sciences (ACHV)

TipRanksJul 13, 2023 07:40 ET

Maxim Group Reaffirms Their Buy Rating on Cingulate Inc (CING)

TipRanksJun 9, 2023 10:35 ET

Maxim Group Remains a Buy on Cingulate Inc (CING)

TipRanksMay 12, 2023 10:25 ET

Maxim Group Keeps Their Buy Rating on Cingulate Inc (CING)

TipRanksMay 5, 2023 10:56 ET

Maxim Group Keeps Their Buy Rating on Cingulate Inc (CING)

TipRanksFeb 25, 2023 07:41 ET

Cingulate Analyst Ratings

Benzinga Analyst RatingsJan 17, 2023 06:23 ET

HC Wainwright & Co. Initiates Coverage On Cingulate With Buy Rating, Announces Price Target of $5.5

Benzinga Real-time NewsJan 17, 2023 06:23 ET

Maxim Group Remains a Buy on Cingulate Inc (CING)

TipRanksDec 8, 2022 15:10 ET